The impetus for much of this work derives from the recognition that techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) offer unparalleled sensitivity for in vivo diagnostic imaging of cancer and other diseases. Developing methods to efficiently construct bifunctional materials featuring radionuclide chelators conjugated to specific bioligands is an important objective in contemporary bioconjugate chemistry.